Metoclopramide Noridem

Metoclopramide Hydrochloride Monohydrate, the active ingredient in Metoclopramide Noridem, is a dopamine antagonist (prokinetic) presented as a sterile injectable solution for intramuscular or intravenous use. It treats nausea, vomiting and gastroparesis in adults.

GNH USA supplies Metoclopramide Noridem as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide Noridem is a dopamine‑antagonist prokinetic used to manage conditions that involve nausea, vomiting or delayed gastric emptying.

Nausea and vomiting: reduces the frequency and severity of episodes. Post‑operative nausea and vomiting: prevents and treats nausea after surgery. Gastroparesis: enhances gastric motility and improves stomach emptying. Migraine‑associated nausea: alleviates nausea accompanying migraine attacks.

Metoclopramide may cause a range of adverse reactions, from mild to severe. Awareness of these effects helps clinicians monitor patients appropriately.

Common Side Effects: - Drowsiness or fatigue. - Restlessness or akathisia. - Diarrhea or abdominal cramping. - Dizziness or headache.

Serious or Rare Side Effects: - Tardive dyskinesia, a potentially irreversible movement disorder. - Neuroleptic malignant syndrome, characterized by fever and muscle rigidity. - Severe allergic reactions such as anaphylaxis. - Hyperprolactinemia leading to galactorrhea or menstrual disturbances. - Seizures, especially in patients with pre‑existing neurological conditions.

Before prescribing Metoclopramide Noridem, clinicians should consider several safety aspects.

Assess renal function: adjust use in patients with severe renal impairment. Monitor for extrapyramidal symptoms: watch for tremor, rigidity, or involuntary movements. Use caution in patients with depression or a history of suicidal ideation. Avoid in individuals with known hypersensitivity to metoclopramide or its excipients. Adjust dose in elderly patients: start with the lowest effective dose. Store at ambient temperature: keep in the original container, protect from light and moisture.

Metoclopramide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): may increase risk of extrapyramidal reactions. - Monoamine‑oxidase inhibitors: can potentiate central nervous system effects. - Strong CYP2D6 inhibitors (e.g., fluoxetine): may raise metoclopramide plasma levels.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may enhance sedation. - Anticholinergic agents: may reduce pro‑kinetic effectiveness.